Metabolite kinetics of ondansetron in rat. Comparison of hepatic microsomes, isolated hepatocytes and liver slices, with in vivo disposition

被引:29
作者
Worboys, PD
Brennan, B
Bradbury, A
Houston, JB
机构
[1] UNIV MANCHESTER,DEPT PHARM,MANCHESTER M13 9PL,LANCS,ENGLAND
[2] GLAXO WELLCOME INC,INT DEV SUPPORT,WARE SG12 0DP,HERTS,ENGLAND
关键词
D O I
10.3109/00498259609052492
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The kinetics of hydroxylation and N-demethylation of ondansetron have been determined in freshly isolated hepatocytes, hepatic microsomes and precision-cut liver slices from the male Sprague-Dawley rat. In vivo studies have also been carried out to characterize the pharmacokinetics of ondansetron and in vitro data have been assessed for their value as predictors of hepatic clearance. 2. In the three in vitro systems, the formation of hydroxylated and demethylated metabolites were characterized as a function of substrate concentration by a high-affinity, low-capacity site and a low-affinity, high-capacity site which was not saturated over the concentration range studied (2.5-500 mu M). Slices gave consistently higher K-m's (20 and 30 mu M for hydroxylation and demethylation respectively) than hepatocytes (3 and 13 mu M respectively) and microsomes (2 and 5 mu M respectively). The rank order of V-max and CL(int) was the same for each system; hydroxylation rates exceeding demethylation rates. Although two hydroxylations (7- and 8-hydroxy metabolites) occurred exclusively in microsomes, these are believed to originate from a common precursor. 3. The high CL(int) of ondansetron (150 ml/min/SRW, where SRW is a standard rat weight of 250 g) is well predicted by scaling either microsomal clearance for microsomal protein recovery or hepatocyte clearance for hepatocellularity (212 and 135 ml/min/SRW respectively). In contrast, the use of liver slice data scaled to a whole liver substantially underestimates CL(int) (9 ml/min/SRW).
引用
收藏
页码:897 / 907
页数:11
相关论文
共 18 条
[1]  
ASHFORTH EIL, 1995, J PHARMACOL EXP THER, V274, P761
[2]  
CARLILE DJ, 1996, UNPUB SCALING FACTOR
[3]   DETERMINATION OF ONDANSETRON IN PLASMA AND ITS PHARMACOKINETICS IN THE YOUNG AND ELDERLY [J].
COLTHUP, PV ;
FELGATE, CC ;
PALMER, JL ;
SCULLY, NL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (09) :868-871
[4]  
COOPER CS, 1983, PROG DRUG METAB, V7, P295
[5]  
DIXON CM, 1995, DRUG METAB DISPOS, V23, P1225
[6]  
FISCHER V, 1994, DRUG METAB DISPOS, V22, P269
[7]  
HAYES KA, 1995, DRUG METAB DISPOS, V23, P353
[8]  
HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469
[9]  
KERR BM, 1993, ISSX P, V4, P137
[10]  
Oxford A W, 1992, Prog Med Chem, V29, P239, DOI 10.1016/S0079-6468(08)70010-9